Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup
NCT ID: NCT03260465
Last Updated: 2025-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
53 participants
INTERVENTIONAL
2017-10-30
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
NCT04618016
A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability
NCT02682654
Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr
NCT03406637
A Novel Shape Memory Alloy-Based Orthosis for Proximal Interphalangeal Joint Stiffness
NCT06716086
Knee Bracing for People With Patellofemoral Osteoarthritis
NCT00381563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
seleXys PC
seleXys PC cup combined with the optimys stem
seleXys PC
Total hip arthroplasty using the seleXys PC cup
RM
RM Pressfit vitamys cup combined with the optimys stem
RM
Total hip arthroplasty using the RM cup
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
seleXys PC
Total hip arthroplasty using the seleXys PC cup
RM
Total hip arthroplasty using the RM cup
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients suitable for an uncemented acetabular component in combination with a 36mm femoral head (seleXys PC cup: 52mm, 54mm or 56mm; RM Pressfit vitamys: 52mm, 54mm or 56mm)
* Patients between the ages of 50 and 75 inclusive
* Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up
Exclusion Criteria
* Patients that offer no guarantee for regular follow-up controls
* Patients that have a revision surgery
* Patients that have a fracture of the femoral neck or a bone tumour in the area of the femur or pelvis
* Patients that had a previous osteotomy of the femur or pelvis
* Pregnant women or those seeking to become pregnant
* Patients with a history of active infection
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karl Stoffel, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Klinik für Orthopädie und Traumatologie, Universitätsspital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Orthopädie und Traumatologie, University Hospital Basel
Basel, Basel-Landschaft, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-00832; mu21Stoffel
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.